 Home > Medical News > Latest Medical News > CD22 ADC: Pfizer's "Inizumab ozogamicin" will be approved soon

CD22 ADC: Pfizer's "Inizumab ozogamicin" will be approved soon

 Last Update: 2021-12-28
 Source: Internet
 Author: User

Tags

3 8 simplified

all edible mushrooms

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 13, Pfizer’s CD22-targeted ADC drug inotuzumab ozomicin entered the administrative approval stage and is expected to be approved in the near future for relapsed or refractory CD22-positive acute lymphoblastic leukemia (ALL).

Inotuzumab ozogamicin (trade name: BESPONSA) is an antibody-drug conjugate (ADC), which consists of a monoclonal antibody (mAb) targeting CD22 and a cytotoxic agent calicheamicin (calicheamicin).

On August 17, 2017, the FDA approved BESPONSA for the treatment of adult relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL)

INO-VATE clinical trial details

From Insight database (http://db.

The results showed that the complete response rate (CR) of patients in the BESPONSA group was 81% (95% CI: 72%-88%), while the data in the chemotherapy group was only 29% (95% CI: 21%-39%)

INO-VATE clinical trial results

From Insight database (http://db.

On January 21, 2020, the drug's application for marketing was accepted by CDE, and it was included in the priority review and approval in March

CD22 ADC global drug under development

From Insight database (http://db.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.